The use of innovative scaffolds in the development of corneal stroma-derived stem cell therapies for future corneal regeneration strategies [Abstract] by Laura E. Sidney (7210094) et al.
The Use of Innovative Scaffolds in the Development 
of Corneal Stroma-Derived Stem Cell Therapies for 
Future Corneal Regeneration Strategies 
Sidney L. E.1, Dunphy S. E.2, Wilson S. L.1, Branch M. J.1, Rose F. R.2, Dua H. S.1, 
Hopkinson A.1;1Academic Ophthalmology, University of Nottingham, Nottingham, UNITED 
KINGDOM2Division of Drug Delivery and Tissue Engineering, University of Nottingham, 
Nottingham, UNITED KINGDOM. 
 
There are 1.5 million cases of corneal blindness diagnosed annually, but only 100,000 corneal 
transplants performed. This is predominantly due to poor access to quality donor tissue. 
Therefore, alternative effective regenerative therapies are required. We have developed a 
bankable corneal stroma-derived stem cell (CSSC) source, for use in corneal regeneration. This 
follow-on work compares the feasibility of substrates to act in combination with CSSC, for the 
development of ocular surface regenerative strategies. 
CSSC extracted from human corneoscleral rims were expanded on three substrates: (i) natural 
amniotic membrane-derived matrix (OmnigenTE™, NuVision™ Ophthalmics); (ii) Ologen 
Collagen Matrix (OCM; Aeon Astron B.V.); and (iii) Dual nano- and microfiber electrospun 
poly(lactic-co glycolic) acid (PLGA) scaffolds. CSSC expansion, proliferation, phenotypic marker 
profile and structural remodelling on the different substrates were assessed. 
CSSC on OmnigenTE formed a monolayer, and maintained a mesenchymal stem cell phenotype 
(CD73+, CD90+, CD105+, CD34−), when cultured on the basement membrane. CSSC infiltrated 
the pores within the OCM and PLGA microfiber scaffolds, and a keratocyte phenotype was 
induced (CD34+, ALDH+, ACTA2−) leading to deposition of collagen and proteoglycans on the 
scaffolds. Addition of corneal epithelial cells onto the pseudo-basement membrane nanofiber 
layer of PLGA further restored normal epithelial-stromal interactions. 
This work demonstrates the ability of different substrates to induce phenotypic changes in CSSC. 
CSSC-OmnigenTE has potential to become a topical stem cell therapy (biological stem cell 
bandage) for acute trauma medicine. OCM and electrospun PLGA induce a keratocyte 
phenotype and thus are more suitable for long-term partial replacement strategies for corneal 
transplantation. 
 
 
 
 
 
 
 
 
 
 
